Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells

被引:18
作者
da Silva, Glenda N. [1 ]
Evangelista, Adriane F. [2 ]
Magalhaes, Danielle A. [2 ]
Macedo, Claudia [2 ]
Bufalo, Michelle C. [3 ]
Sakamoto-Hojo, Elza T. [2 ,4 ]
Passos, Geraldo A. S. [2 ,5 ]
Salvadori, Daisy M. F. [1 ]
机构
[1] Sao Paulo State Univ, UNESP, Fac Med Botucatu, Botucatu Med Sch, BR-18618000 Botucatu, SP, Brazil
[2] Univ Sao Paulo, Fac Med, BR-14049 Ribeirao Preto, SP, Brazil
[3] Univ Sao Paulo, UNESP, Biosci Inst, Botucatu, SP, Brazil
[4] Univ Sao Paulo, Dept Biol FFCLRP, BR-14049 Ribeirao Preto, SP, Brazil
[5] Univ Sao Paulo, Fac Dent, BR-14049 Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Gene expression; Gene network; TP53; Urinary bladder transitional cell carcinoma; FUNCTIONAL-ANALYSIS; CDNA MICROARRAYS; P53; PROTEIN; PROFILES; LINES; SENSITIVITY; METASTASIS; MUTATIONS; BINDING;
D O I
10.1007/s11033-010-0536-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urinary bladder cancer is the fourth most common malignancy in the Western world. Transitional cell carcinoma (TCC) is the most common subtype, accounting for about 90% of all bladder cancers. The TP53 gene plays an essential role in the regulation of the cell cycle and apoptosis and therefore contributes to cellular transformation and malignancy; however, little is known about the differential gene expression patterns in human tumors that present with the wild-type or mutated TP53 gene. Therefore, because gene profiling can provide new insights into the molecular biology of bladder cancer, the present study aimed to compare the molecular profiles of bladder cancer cell lines with different TP53 alleles, including the wild type (RT4) and two mutants (5637, with mutations in codons 280 and 72; and T24, a TP53 allele encoding an in-frame deletion of tyrosine 126). Unsupervised hierarchical clustering and gene networks were constructed based on data generated by cDNA microarrays using mRNA from the three cell lines. Differentially expressed genes related to the cell cycle, cell division, cell death, and cell proliferation were observed in the three cell lines. However, the cDNA microarray data did not cluster cell lines based on their TP53 allele. The gene profiles of the RT4 cells were more similar to those of T24 than to those of the 5637 cells. While the deregulation of both the cell cycle and the apoptotic pathways was particularly related to TCC, these alterations were not associated with the TP53 status.
引用
收藏
页码:4159 / 4170
页数:12
相关论文
共 50 条
[1]  
[Anonymous], FatiGO
[2]  
[Anonymous], Source
[3]  
[Anonymous], 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB1906S77
[4]   Bladder cancer outcome and subtype classification by gene expression [J].
Blaveri, E ;
Simko, JP ;
Korkola, JE ;
Brewer, JL ;
Baehner, F ;
Mehta, K ;
DeVries, S ;
Koppie, T ;
Pejavar, S ;
Carroll, P ;
Waldman, FM .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :4044-4055
[5]   When mutants gain new powers: news from the mutant p53 field [J].
Brosh, Ran ;
Rotter, Varda .
NATURE REVIEWS CANCER, 2009, 9 (10) :701-713
[6]   The treated natural history of high risk superficial bladder cancer: 15-year outcome [J].
Cookson, MS ;
Herr, HW ;
Zhang, ZF ;
Soloway, S ;
Sogani, PC ;
Fair, WR .
JOURNAL OF UROLOGY, 1997, 158 (01) :62-67
[7]  
COOPER MJ, 1994, ONCOL RES, V6, P569
[8]   Do DNA microarrays have their future behind them? [J].
Coppee, Jean-Yves .
MICROBES AND INFECTION, 2008, 10 (09) :1067-1071
[9]   Molecular alterations associated with bladder cancer initiation and progression [J].
Cordon-Cardo, Carlos .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2008, 42 :154-165
[10]   Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine [J].
da Silva, Glenda Nicioli ;
de Castro Marcondes, Joao Paulo ;
de Camargo, Elaine Aparecida ;
da Silva Passos Junior, Geraldo Aleixo ;
Sakamoto-Hojo, Elza Tiemi ;
Favero Salvadori, Daisy Maria .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 235 (07) :814-824